These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 2957533)
21. Statement on immunizing agents for the prevention of hepatitis. CMAJ; 1985 Sep; 133(6):581-5. PubMed ID: 3161607 [No Abstract] [Full Text] [Related]
22. [Anti-HAV and anti-HBs antibodies in immunoglobulin preparations]. Radović M; Mijusković P; Ross M; Damjanović V; Taseski J; Vondracek O Vojnosanit Pregl; 1985; 42(1):3-9. PubMed ID: 3984239 [No Abstract] [Full Text] [Related]
23. [Round table and a multidisciplinary discussion]. Alagille D; Buts ; Cadranel ; Dachy ; Desmyter ; Donea B; Geubel ; Thiry L; Toussaint C Rev Med Liege; 1984 Oct; 39(20):722-40. PubMed ID: 6438754 [No Abstract] [Full Text] [Related]
24. Viral hepatitis: A, B, C, D, and E--prevention. Krugman S Pediatr Rev; 1992 Jul; 13(7):245-7. PubMed ID: 1535710 [No Abstract] [Full Text] [Related]
25. [Prevention of perinatal transmission of hepatitis B virus infection by HB-Ig and HB-vaccine]. Ohryohji F; Umezu T; Ootsuka M; Kanda S Fukuoka Igaku Zasshi; 1984 Oct; 75(10):594-7. PubMed ID: 6240438 [No Abstract] [Full Text] [Related]
26. A comparison between the efficacy of passive-active and active immunization for prevention of perinatal transmission of hepatitis B virus. Theppisai U; Thanuntaseth C; Chiewsilp P; Siripoonya P J Med Assoc Thai; 1987 Aug; 70(8):459-62. PubMed ID: 3681171 [No Abstract] [Full Text] [Related]
27. A two dose schedule for combined hepatitis A and hepatitis B vaccination in children ages one to eleven years. Van Der Wielen M; Van Damme P; Collard F Pediatr Infect Dis J; 2000 Sep; 19(9):848-53. PubMed ID: 11001108 [TBL] [Abstract][Full Text] [Related]
28. [Clinical problems of chronic hepatitis]. Bliuger AF Klin Med (Mosk); 1980 Sep; 58(9):16-23. PubMed ID: 6997608 [No Abstract] [Full Text] [Related]
29. Control measures against hepatitis B infection. Frösner GG; Franco E Ann Ist Super Sanita; 1987; 24(2):267-75. PubMed ID: 2969204 [No Abstract] [Full Text] [Related]
30. [Later revision of patients hospitalized with viral acute hepatitis (author's transl)]. Ajolfi C; Fornari F; Buscarini L Ann Sclavo; 1980; 22(2):109-15. PubMed ID: 6781420 [TBL] [Abstract][Full Text] [Related]
32. Viral hepatitis: update on prevention. Alter MJ Henry Ford Hosp Med J; 1984; 32(2):101-6. PubMed ID: 6439691 [No Abstract] [Full Text] [Related]
33. Protection against viral hepatitis. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Recomm Rep; 1990 Feb; 39(RR-2):1-26. PubMed ID: 2153904 [No Abstract] [Full Text] [Related]
34. Viral hepatitis research leading towards control by vaccination. Melnick JL; Hollinger FB; Dreesman GR Arch Roum Pathol Exp Microbiol; 1976; 35(1-2):5-65. PubMed ID: 64239 [No Abstract] [Full Text] [Related]
35. Predictive value of markers of hepatitis virus infection. Deinhardt F J Infect Dis; 1980 Mar; 141(3):299-305. PubMed ID: 6245154 [No Abstract] [Full Text] [Related]
36. [Immunopathogenic aspects of chronic viral hepatitis]. Moreno Otero R; García Buey L; García Monzón C Rev Clin Esp; 1996 Mar; 196(3):179-84. PubMed ID: 8650389 [No Abstract] [Full Text] [Related]
38. [Specific immunological profile of candidates for hepatitis A]. Hainaut J; Dutertre J; Laverdant C Ann Med Interne (Paris); 1984; 135(6):444-8. PubMed ID: 6439093 [TBL] [Abstract][Full Text] [Related]
39. Prevention of hepatitis B transmission at birth. Schalm SW; Pit-Grosheide P Lancet; 1989 Jan; 1(8628):44. PubMed ID: 2563023 [No Abstract] [Full Text] [Related]
40. [Epidemiology, clinical aspects and prognosis of viral hepatitis A, B and non-A, non-B]. Judmaier G Acta Med Austriaca Suppl; 1988; 37():1-31. PubMed ID: 3132025 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]